177 related articles for article (PubMed ID: 21297967)
1. Label-free proteomics reveals decreased expression of CD18 and AKNA in peripheral CD4+ T cells from patients with Vogt-Koyanagi-Harada syndrome.
Mao L; Yang P; Hou S; Li F; Kijlstra A
PLoS One; 2011 Jan; 6(1):e14616. PubMed ID: 21297967
[TBL] [Abstract][Full Text] [Related]
2. The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease.
Sun M; Yang P; Du L; Yang Y; Ye J
PLoS One; 2014; 9(4):e93214. PubMed ID: 24690905
[TBL] [Abstract][Full Text] [Related]
3. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
[TBL] [Abstract][Full Text] [Related]
4. Decreased 1,25-Dihydroxyvitamin D3 level is involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.
Yi X; Yang P; Sun M; Yang Y; Li F
Mol Vis; 2011 Mar; 17():673-9. PubMed ID: 21403851
[TBL] [Abstract][Full Text] [Related]
5. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease.
Chi W; Yang P; Li B; Wu C; Jin H; Zhu X; Chen L; Zhou H; Huang X; Kijlstra A
J Allergy Clin Immunol; 2007 May; 119(5):1218-24. PubMed ID: 17335887
[TBL] [Abstract][Full Text] [Related]
6. [Ocular infiltrating CD 4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens].
Sugita S
Nippon Ganka Gakkai Zasshi; 2008 Nov; 112(11):953-64. PubMed ID: 19069378
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of proinflammatory cytokine by IL-25 in Vogt-Koyanagi-Harada syndrome.
Xu M; Wang C; Tian Y; Kijlstra A; Yang P
Ocul Immunol Inflamm; 2014 Aug; 22(4):294-9. PubMed ID: 24329541
[TBL] [Abstract][Full Text] [Related]
8. Disturbed expression of Fas/FasL on CD4(+) and CD8(+)T cells in Behcet's disease, Vogt-Koyanagi-Harada syndrome, and idiopathic anterior uveitis.
Yang P; Ji L; Zhou H; Huang X; Xie C; Jin H; Chen L; Kijlstra A
Ocul Immunol Inflamm; 2001 Sep; 9(3):185-91. PubMed ID: 11815887
[TBL] [Abstract][Full Text] [Related]
9. TET2-mediated upregulation of 5-hydroxymethylcytosine in LRRC39 promoter promotes Th1 response in association with downregulated Treg response in Vogt-Koyanagi-Harada disease.
Zhang W; Chen Z; Yi K; Su G; Liu Y; Deng Y; Zhang Y; Cao Q; Pu Y; Luo X; Lai Y; Yang P
Clin Immunol; 2023 May; 250():109323. PubMed ID: 37019422
[TBL] [Abstract][Full Text] [Related]
10. Increased IL-7 expression in Vogt-Koyanagi-Harada disease.
Yang Y; Xiao X; Li F; Du L; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):1012-7. PubMed ID: 22247488
[TBL] [Abstract][Full Text] [Related]
11. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome.
Commodaro AG; Peron JP; Genre J; Arslanian C; Sanches L; Muccioli C; Rizzo LV; Belfort R
Scand J Immunol; 2010 Jul; 72(1):31-7. PubMed ID: 20591073
[TBL] [Abstract][Full Text] [Related]
12. Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.
Abad S; Wieërs G; Colau D; Wildmann C; Delair E; Dhote R; Brézin AP; Kawakami Y; Coulie PG; van der Bruggen P
Mol Vis; 2014; 20():956-69. PubMed ID: 24991188
[TBL] [Abstract][Full Text] [Related]
13. Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.
Peng Z; Jiang S; Wu M; Zhou X; Wang Q
Mol Vis; 2017; 23():538-547. PubMed ID: 28761327
[TBL] [Abstract][Full Text] [Related]
14. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.
Sugita S; Takase H; Taguchi C; Imai Y; Kamoi K; Kawaguchi T; Sugamoto Y; Futagami Y; Itoh K; Mochizuki M
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2547-54. PubMed ID: 16723469
[TBL] [Abstract][Full Text] [Related]
15. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease.
Wang C; Tian Y; Lei B; Xiao X; Ye Z; Li F; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4668-75. PubMed ID: 22669715
[TBL] [Abstract][Full Text] [Related]
16. Integrated omics analysis of sweat reveals an aberrant amino acid metabolism pathway in Vogt-Koyanagi-Harada disease.
Cui X; Su G; Zhang L; Yi S; Cao Q; Zhou C; Kijlstra A; Yang P
Clin Exp Immunol; 2020 Jun; 200(3):250-259. PubMed ID: 32222072
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of T-bet expression in peripheral blood mononuclear cells during Vogt-Koyanagi-Harada disease.
Li B; Yang P; Zhou H; Huang X; Jin H; Chu L; Gao Y; Zhu L; Kijlstra A
Br J Ophthalmol; 2005 Nov; 89(11):1410-2. PubMed ID: 16234441
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 expression by CD4 T lymphocytes in Vogt-Koyanagi-Harada disease.
Ohta K; Yoshimura N
Ocul Immunol Inflamm; 2002 Jun; 10(2):93-103. PubMed ID: 12778345
[TBL] [Abstract][Full Text] [Related]
19. Proteomics Profiling of Plasma Exosomes in VKH Patients.
Zheng H; Yang F; Ea V; Zhou L; Wu L; Zhao G; Shao X; Jiang Y; Huang Y; Li X; Zhang X
Curr Mol Med; 2021; 21(8):675-689. PubMed ID: 32682377
[TBL] [Abstract][Full Text] [Related]
20. Disabled-2 (DAB2) Overexpression Inhibits Monocyte-Derived Dendritic Cells' Function in Vogt-Koyanagi-Harada Disease.
Yi S; Chang R; Hu J; Qiu Y; Wang Q; Cao Q; Yuan G; Su G; Zhou C; Wang Y; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4662-4669. PubMed ID: 30267088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
